Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.430
+0.080 (5.93%)
At close: Apr 17, 2025, 4:00 PM
1.490
+0.060 (4.20%)
After-hours: Apr 17, 2025, 5:54 PM EDT

Autolus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3816251,120329378468
Upgrade
Market Cap Growth
-44.17%-44.17%240.67%-13.12%-19.06%-21.26%
Upgrade
Enterprise Value
902691,057233227343
Upgrade
Last Close Price
1.432.356.441.905.198.94
Upgrade
PS Ratio
36.0661.80659.6951.70162.43272.63
Upgrade
PB Ratio
0.891.4610.051.101.212.23
Upgrade
P/TBV Ratio
0.921.5110.051.101.212.23
Upgrade
EV/Sales Ratio
8.8726.63622.4836.6997.51199.84
Upgrade
Debt / Equity Ratio
0.700.702.010.500.220.26
Upgrade
Asset Turnover
0.020.020.000.010.010.01
Upgrade
Quick Ratio
10.4810.485.908.8711.795.44
Upgrade
Current Ratio
10.8810.886.159.1812.155.86
Upgrade
Return on Equity (ROE)
-81.91%-81.91%-101.61%-48.64%-54.30%-61.13%
Upgrade
Return on Assets (ROA)
-25.99%-25.99%-25.35%-19.94%-25.07%-35.16%
Upgrade
Return on Capital (ROIC)
-28.40%-28.40%-27.98%-21.52%-27.18%-38.55%
Upgrade
Earnings Yield
-5798.28%-35.28%-18.60%-45.27%-37.55%-30.39%
Upgrade
FCF Yield
-6000.19%-36.51%-13.98%-37.45%-33.48%-28.33%
Upgrade
Buyback Yield / Dilution
-4669.30%-46.69%-83.11%-31.78%-39.81%-19.72%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q